APO Research
Talk to an analyst

APO RESEARCH · REPORT

Apixaban

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Apixaban Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchApixaban Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Apixaban Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Apixaban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apixaban Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Apixaban Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Apixaban market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Apixaban include Pfizer, Polpharma, Medichem, Dipharma Francis, DEAFARMA, Centaur Pharmaceutical and Beijing Cooperate Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Apixaban market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Apixaban market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Apixaban market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Apixaban.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Apixaban market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Apixaban Market by Company

Pfizer

Polpharma

Medichem

Dipharma Francis

DEAFARMA

Centaur Pharmaceutical

Beijing Cooperate Pharmaceutical

Apixaban Segment by Type

Capsule Apixaban

Tablet Apixaban

Apixaban Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Apixaban Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apixaban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apixaban and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apixaban.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Apixaban manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Apixaban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Apixaban Table 2. Major Company of Tablet Apixaban Table 3. Global Apixaban Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Apixaban Sales by Type (2021-2026) & (k units) Table 5. Global Apixaban Sales Market Share in Volume by Type (2021-2026) Table 6. Global Apixaban Sales by Type (2021-2026) & (US$ Million) Table 7. Global Apixaban Sales Market Share in Value by Type (2021-2026) Table 8. Global Apixaban Price by Type (2021-2026) & (US$/unit) Table 9. Global Apixaban Sales by Type (2027-2032) & (k units) Table 10. Global Apixaban Sales Market Share in Volume by Type (2027-2032) Table 11. Global Apixaban Sales by Type (2027-2032) & (US$ Million) Table 12. Global Apixaban Sales Market Share in Value by Type (2027-2032) Table 13. Global Apixaban Price by Type (2027-2032) & (US$/unit) Table 14. North America Apixaban Sales by Type (2021-2026) & (k units) Table 15. North America Apixaban Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Apixaban Sales by Type (2021-2026) & (k units) Table 17. Europe Apixaban Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Apixaban Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Apixaban Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Apixaban Sales by Type (2021-2026) & (k units) Table 21. Latin America Apixaban Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Apixaban Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Apixaban Sales by Type (2021-2026) & (US$ Million) Table 24. Apixaban Industry Trends Table 25. Apixaban Industry Drivers Table 26. Apixaban Industry Opportunities and Challenges Table 27. Apixaban Industry Restraints Table 28. Global Apixaban Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Apixaban Revenue Market Share by Company (2021-2026) Table 30. Global Apixaban Sales by Company (2021-2026) & (k units) Table 31. Global Apixaban Sales Share by Company (2021-2026) Table 32. Global Apixaban Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Apixaban Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Apixaban Major Company Production Sites and Headquarters Table 35. Global Apixaban Company, Product Type & Application Table 36. Global Apixaban Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Apixaban by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Apixaban Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Apixaban Sales by Region (2021-2026) & (k units) Table 41. Global Apixaban Sales Market Share in Volume by Region (2021-2026) Table 42. Global Apixaban Sales by Region (2021-2026) & (US$ Million) Table 43. Global Apixaban Sales Market Share in Value by Region (2021-2026) Table 44. Global Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Apixaban Sales by Region (2027-2032) & (k units) Table 46. Global Apixaban Sales Market Share in Volume by Region (2027-2032) Table 47. Global Apixaban Sales by Region (2027-2032) & (US$ Million) Table 48. Global Apixaban Sales Market Share in Value by Region (2027-2032) Table 49. Global Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Apixaban Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Apixaban Sales by Application (2021-2026) & (k units) Table 52. Global Apixaban Sales Market Share in Volume by Application (2021-2026) Table 53. Global Apixaban Sales by Application (2021-2026) & (US$ Million) Table 54. Global Apixaban Sales Market Share in Value by Application (2021-2026) Table 55. Global Apixaban Price by Application (2021-2026) & (US$/unit) Table 56. Global Apixaban Sales by Application (2027-2032) & (k units) Table 57. Global Apixaban Sales Market Share in Volume by Application (2027-2032) Table 58. Global Apixaban Sales by Application (2027-2032) & (US$ Million) Table 59. Global Apixaban Sales Market Share in Value by Application (2027-2032) Table 60. Global Apixaban Price by Application (2027-2032) & (US$/unit) Table 61. North America Apixaban Sales by Application (2021-2026) & (k units) Table 62. North America Apixaban Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Apixaban Sales by Application (2021-2026) & (k units) Table 64. Europe Apixaban Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Apixaban Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Apixaban Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Apixaban Sales by Application (2021-2026) & (k units) Table 68. Latin America Apixaban Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Apixaban Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Apixaban Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Pfizer Apixaban Product Portfolio Table 75. Pfizer Recent Development Table 76. Polpharma Company Information Table 77. Polpharma Business Overview Table 78. Polpharma Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Polpharma Apixaban Product Portfolio Table 80. Polpharma Recent Development Table 81. Medichem Company Information Table 82. Medichem Business Overview Table 83. Medichem Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Medichem Apixaban Product Portfolio Table 85. Medichem Recent Development Table 86. Dipharma Francis Company Information Table 87. Dipharma Francis Business Overview Table 88. Dipharma Francis Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Dipharma Francis Apixaban Product Portfolio Table 90. Dipharma Francis Recent Development Table 91. DEAFARMA Company Information Table 92. DEAFARMA Business Overview Table 93. DEAFARMA Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. DEAFARMA Apixaban Product Portfolio Table 95. DEAFARMA Recent Development Table 96. Centaur Pharmaceutical Company Information Table 97. Centaur Pharmaceutical Business Overview Table 98. Centaur Pharmaceutical Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Centaur Pharmaceutical Apixaban Product Portfolio Table 100. Centaur Pharmaceutical Recent Development Table 101. Beijing Cooperate Pharmaceutical Company Information Table 102. Beijing Cooperate Pharmaceutical Business Overview Table 103. Beijing Cooperate Pharmaceutical Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Beijing Cooperate Pharmaceutical Apixaban Product Portfolio Table 105. Beijing Cooperate Pharmaceutical Recent Development Table 106. North America Apixaban Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Apixaban Sales by Country (2021-2026) & (k units) Table 108. North America Apixaban Sales Market Share by Country (2021-2026) Table 109. North America Apixaban Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Apixaban Sales Market Share Forecast by Country (2027-2032) Table 111. North America Apixaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Apixaban Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Apixaban Market Share by Country (2021-2026) Table 114. North America Apixaban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Apixaban Market Share Forecast by Country (2027-2032) Table 116. Europe Apixaban Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Apixaban Sales by Country (2021-2026) & (k units) Table 118. Europe Apixaban Sales Market Share by Country (2021-2026) Table 119. Europe Apixaban Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Apixaban Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Apixaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Apixaban Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Apixaban Market Share by Country (2021-2026) Table 124. Europe Apixaban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Apixaban Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Apixaban Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Apixaban Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Apixaban Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Apixaban Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Apixaban Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Apixaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Apixaban Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Apixaban Market Share by Country (2021-2026) Table 134. Asia-Pacific Apixaban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Apixaban Market Share Forecast by Country (2027-2032) Table 136. Latin America Apixaban Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Apixaban Sales by Country (2021-2026) & (k units) Table 138. Latin America Apixaban Sales Market Share by Country (2021-2026) Table 139. Latin America Apixaban Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Apixaban Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Apixaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Apixaban Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Apixaban Market Share by Country (2021-2026) Table 144. Latin America Apixaban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Apixaban Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Apixaban Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Apixaban Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Apixaban Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Apixaban Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Apixaban Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Apixaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Apixaban Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Apixaban Market Share by Country (2021-2026) Table 154. Middle East and Africa Apixaban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Apixaban Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Apixaban Distributors List Table 159. Apixaban Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Apixaban Image Figure 2. Global Apixaban Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apixaban Market Size (2021-2032) & (US$ Million) Figure 4. Global Apixaban Sales (2021-2032) & (k units) Figure 5. Capsule Apixaban Image Figure 6. Global Capsule Apixaban Sales YoY Growth (2021-2032) & (k units) Figure 7. Tablet Apixaban Image Figure 8. Global Tablet Apixaban Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Apixaban Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Apixaban Market Share by Type 2025 VS 2032 Figure 11. North America Apixaban Sales Market Share in Volume by Type in 2025 Figure 12. North America Apixaban Sales Market Share in Value by Type in 2025 Figure 13. Europe Apixaban Sales Market Share in Volume by Type in 2025 Figure 14. Europe Apixaban Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Apixaban Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Apixaban Sales Market Share in Value by Type in 2025 Figure 17. Latin America Apixaban Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Apixaban Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Apixaban Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Apixaban Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Apixaban Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 25. Online Pharmacy Image Figure 26. Global Online Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Apixaban Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Apixaban Market Share by Application 2025 VS 2032 Figure 31. North America Apixaban Sales Market Share in Volume by Application in 2025 Figure 32. North America Apixaban Sales Market Share in Value by Application in 2025 Figure 33. Europe Apixaban Sales Market Share in Volume by Application in 2025 Figure 34. Europe Apixaban Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Apixaban Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Apixaban Sales Market Share in Value by Application in 2025 Figure 37. Latin America Apixaban Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Apixaban Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Apixaban Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Apixaban Sales Market Share in Value by Application in 2025 Figure 41. North America Apixaban Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Apixaban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Apixaban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Apixaban Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Apixaban Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Apixaban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Apixaban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Apixaban Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Apixaban Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Apixaban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Apixaban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Apixaban Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Apixaban Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Apixaban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Apixaban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Apixaban Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Apixaban Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Apixaban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Apixaban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Apixaban Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Apixaban Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Apixaban Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule Apixaban
  • Tablet Apixaban
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Pfizer
  • Polpharma
  • Medichem
  • Dipharma Francis
  • DEAFARMA
  • Centaur Pharmaceutical
  • Beijing Cooperate Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Apixaban Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Apixaban Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Apixaban Market by Type
  6. 1.3.1 Capsule Apixaban
  7. 1.3.2 Tablet Apixaban
  8. 1.4 Global Apixaban Market Size by Type
  9. 1.4.1 Global Apixaban Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Apixaban Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Apixaban Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Apixaban Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Apixaban Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Apixaban Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Apixaban Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Apixaban Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Apixaban Industry Trends
  2. 2.2 Apixaban Industry Drivers
  3. 2.3 Apixaban Industry Opportunities and Challenges
  4. 2.4 Apixaban Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Apixaban Revenue (2021-2026)
  2. 3.2 Global Top Players by Apixaban Sales (2021-2026)
  3. 3.3 Global Top Players by Apixaban Price (2021-2026)
  4. 3.4 Global Apixaban Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Apixaban Major Company Production Sites & Headquarters
  6. 3.6 Global Apixaban Company, Product Type & Application
  7. 3.7 Global Apixaban Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Apixaban Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Apixaban Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Apixaban Tier 1, Tier 2, and Tier 3
4 Apixaban Regional Status and Outlook
  1. 4.1 Global Apixaban Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Apixaban Historic Market Size by Region
  3. 4.2.1 Global Apixaban Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Apixaban Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Apixaban Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Apixaban Forecasted Market Size by Region
  7. 4.3.1 Global Apixaban Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Apixaban Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Apixaban Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Apixaban by Application
  1. 5.1 Apixaban Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Apixaban Market Size by Application
  6. 5.2.1 Global Apixaban Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Apixaban Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Apixaban Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Apixaban Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Apixaban Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Apixaban Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Apixaban Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Apixaban Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Apixaban Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Apixaban Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Polpharma
  8. 6.2.1 Polpharma Company Information
  9. 6.2.2 Polpharma Business Overview
  10. 6.2.3 Polpharma Apixaban Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Polpharma Apixaban Product Portfolio
  12. 6.2.5 Polpharma Recent Developments
  13. 6.3 Medichem
  14. 6.3.1 Medichem Company Information
  15. 6.3.2 Medichem Business Overview
  16. 6.3.3 Medichem Apixaban Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medichem Apixaban Product Portfolio
  18. 6.3.5 Medichem Recent Developments
  19. 6.4 Dipharma Francis
  20. 6.4.1 Dipharma Francis Company Information
  21. 6.4.2 Dipharma Francis Business Overview
  22. 6.4.3 Dipharma Francis Apixaban Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dipharma Francis Apixaban Product Portfolio
  24. 6.4.5 Dipharma Francis Recent Developments
  25. 6.5 DEAFARMA
  26. 6.5.1 DEAFARMA Company Information
  27. 6.5.2 DEAFARMA Business Overview
  28. 6.5.3 DEAFARMA Apixaban Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 DEAFARMA Apixaban Product Portfolio
  30. 6.5.5 DEAFARMA Recent Developments
  31. 6.6 Centaur Pharmaceutical
  32. 6.6.1 Centaur Pharmaceutical Company Information
  33. 6.6.2 Centaur Pharmaceutical Business Overview
  34. 6.6.3 Centaur Pharmaceutical Apixaban Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Centaur Pharmaceutical Apixaban Product Portfolio
  36. 6.6.5 Centaur Pharmaceutical Recent Developments
  37. 6.7 Beijing Cooperate Pharmaceutical
  38. 6.7.1 Beijing Cooperate Pharmaceutical Company Information
  39. 6.7.2 Beijing Cooperate Pharmaceutical Business Overview
  40. 6.7.3 Beijing Cooperate Pharmaceutical Apixaban Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Cooperate Pharmaceutical Apixaban Product Portfolio
  42. 6.7.5 Beijing Cooperate Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Apixaban Sales by Country
  2. 7.1.1 North America Apixaban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Apixaban Sales by Country (2021-2026)
  4. 7.1.3 North America Apixaban Sales Forecast by Country (2027-2032)
  5. 7.2 North America Apixaban Market Size by Country
  6. 7.2.1 North America Apixaban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Apixaban Market Size by Country (2021-2026)
  8. 7.2.3 North America Apixaban Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Apixaban Sales by Country
  2. 8.1.1 Europe Apixaban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Apixaban Sales by Country (2021-2026)
  4. 8.1.3 Europe Apixaban Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Apixaban Market Size by Country
  6. 8.2.1 Europe Apixaban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Apixaban Market Size by Country (2021-2026)
  8. 8.2.3 Europe Apixaban Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Apixaban Sales by Country
  2. 9.1.1 Asia-Pacific Apixaban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Apixaban Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Apixaban Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Apixaban Market Size by Country
  6. 9.2.1 Asia-Pacific Apixaban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Apixaban Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Apixaban Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Apixaban Sales by Country
  2. 10.1.1 South America Apixaban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Apixaban Sales by Country (2021-2026)
  4. 10.1.3 South America Apixaban Sales Forecast by Country (2027-2032)
  5. 10.2 South America Apixaban Market Size by Country
  6. 10.2.1 South America Apixaban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Apixaban Market Size by Country (2021-2026)
  8. 10.2.3 South America Apixaban Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Apixaban Sales by Country
  2. 11.1.1 Middle East and Africa Apixaban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Apixaban Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Apixaban Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Apixaban Market Size by Country
  6. 11.2.1 Middle East and Africa Apixaban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Apixaban Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Apixaban Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Apixaban Value Chain Analysis
  2. 12.1.1 Apixaban Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Apixaban Production Mode & Process
  7. 12.2 Apixaban Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Apixaban Distributors
  10. 12.2.3 Apixaban Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst